Takeda-6D
Based on 1 Customer Validation
Takeda-6D (compound 6d) is an orally active and potent BRAF/VEGFR2 inhibitor, with IC50 values of 7.0 and 2.2 nM, respectively. Takeda-6D shows antiangiogenesis by suppressing the VEGFR2 pathway in 293/KDR and VEGF-stimulated HUVEC cells.Takeda-6D shows significant suppression of ERK1/2 phosphorylation. Takeda-6D shows antitumor activity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.41%
- CAS 番号: 1125632-93-0
- 分子式: C27H19ClFN5O3S
- 分子量:547.99
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
VEGFR アイソフォーム固有の製品をすべて表示
More
生物活性
|
VEGFR2 2.2 nM (IC50) |
Braf 7.0 nM (IC50) |
Takeda-6D (0-10 mg/kg, Orally, once) significantly decreases phosphorylation levels of ERK1/24 h after oral administration in an A375 (BRAFV600E mutant) human melanoma xenograft model in rats[1].
Takeda-6D (10 mg/kg, Orally, twice daily for 2 weeks) shows tumor regression with T/Cof −7.0% without severe toxicity, and this tumor regression should include the efficacy based on the antiangiogenesis potency and BRAF inhibitory activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 1125632-93-0
-
性状 Solid
-
分子量 547.99
-
分子式 C27H19ClFN5O3S
-
Color White to light yellow
-
SMILES
O=C(NC1=CC(OC2=CC=C3C(SC(NC(C4CC4)=O)=N3)=N2)=CC=C1F)C5=CC=CC(C6(C#N)CC6)=C5Cl
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 50 mg/mL (91.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (270 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.8249 mL | 9.1243 mL | 18.2485 mL | 45.6213 mL |
| 5 mM | 0.3650 mL | 1.8249 mL | 3.6497 mL | 9.1243 mL | |
| 10 mM | 0.1825 mL | 0.9124 mL | 1.8249 mL | 4.5621 mL | |
| 15 mM | 0.1217 mL | 0.6083 mL | 1.2166 mL | 3.0414 mL | |
| 20 mM | 0.0912 mL | 0.4562 mL | 0.9124 mL | 2.2811 mL | |
| 25 mM | 0.0730 mL | 0.3650 mL | 0.7299 mL | 1.8249 mL | |
| 30 mM | 0.0608 mL | 0.3041 mL | 0.6083 mL | 1.5207 mL | |
| 40 mM | 0.0456 mL | 0.2281 mL | 0.4562 mL | 1.1405 mL | |
| 50 mM | 0.0365 mL | 0.1825 mL | 0.3650 mL | 0.9124 mL | |
| 60 mM | 0.0304 mL | 0.1521 mL | 0.3041 mL | 0.7604 mL | |
| 80 mM | 0.0228 mL | 0.1141 mL | 0.2281 mL | 0.5703 mL |